Our breakthrough AI and cutting edge bioelectronics provide peace of mind to those affected by neurological injury and empower physicians to diagnose and treat with precision
Provide expert level brain health monitoring in all settings
Reliable Artificial Intelligence
Comfortable Brain Interfaces
Neurological injury detection made simple and easy
Just like the presentation of arrhythmia on EKG, neurological injuries induce specific patterns in EEG. Our technology identifies these signature patterns immediately and enables fast diagnosis and treatment.
10 million Americans live with a risk of stroke
Less than 10% of stroke victims in the US receive treatment
1 in 10 of all ischemic stroke victims die each year
1 in 10 patients hospitalized with traumatic brain injury will develop seizures
1 in 4 patients admitted to neurocritical care has seizures without visible shaking
The sooner a seizure gets treated, the more likely it is to respond to the intervention
Continuous monitoring of multiple patients
Automated pre-screening and annotation of large datasets
Seamless integration with existing EEG systems
Peace of mind for patients and their families
Faster access to life-saving treatment
Insightful patient management and recovery
Zeit Medical was founded with a promise to create a real change in the way we identify and provide therapy for neurological conditions. Originating from the flagship program of Stanford Biodesign, our work is inspired by the principles of design thinking and value driven care. We take great pride in staying patient-centered and are advised not only by physicians but also patients with first hand experience around stroke.
Ceo
Orestis Vardoulis, PhD
Orestis has a decade of experience in developing non-invasive and wearable health monitoring technologies. Orestis holds a PhD in Biotechnology and Bioengineering from Federal Institute of Technology in Lausanne (EPFL), Switzerland. Orestis has conducted cutting edge research at Stanford University and has been awarded a variety of grants and awards. He has authored 20+ publications in prestigious journals and has filed for a variety of patents at the intersection of materials technology and medical devices. Most recently Orestis was a Stanford Biodesign Innovation Fellow and since the founding of Zeit Medical he has been focusing on his CEO role and Zeit's RnD. Orestis lives in San Francisco, and he keeps close ties with the medical technology communities in Switzerland and Greece contributing to regional Biodesign educational workshops.
CMO/COO
Urs Naber, MD
Urs is a pediatric critical care physician with over a decade of clinical care experience and has participated in breakthrough bench top, clinical and educational research at Dartmouth and Stanford University. Urs has contributed to several pediatric medical devices development projects, prior to joining the Stanford Biodesign Fellowship program. Urs has also spent time in Shanghai and Beijing working with a med-tech focused private equity company and closely follows the regulatory developments in Europe and Asia. Urs manages operations, patient & clinical relationships, and structuring the company’s regulatory path as the CMO of Zeit Medical. Urs also maintains a clinical role in the pediatric critical care unit of Valley Children’s hospital.
